Industry Sector

Biopharma

From pre-clinical stages to commercialization and Loss of Exclusivity (LoE), our focus includes brand and portfolio strategies, encompassing key functional and cross-functional expertise. Over the last two decades, we've served large-cap Pharma and clinical-stage/commercial-stage Biotech companies across diverse functions and departments.

Our industry experts support clients across every aspect of early-stage and commercial-stage development to help them unlock their full potential and accelerate market entry.

Success Stories

Developed comprehensive Payer Portfolio Offerings, including Services and Payment Strategies in several emerging markets, including the Middle East, Gulf Countries, Saudi Arabia and LATAM​

Customized brand value proposition for Cardiology customer segments to inform key launch elements of a small Biotech’s first launched product

Developed a rare liver disease market landscape for an investment group looking to identify potential acquisition targets for an expansion to the U.S. market and performed commercial due diligence resulting in an acquisition of over $2B

Defined investment criteria, including the business model and P&L, allowing an investment management company seeking to expand their life sciences practice

Identified emotional drivers influencing treatment selection at specific points in the patient journey for a rare disease

Developed a market map to inform a mid-size GTx manufacturer’s commercial strategy and launch planning

Experts

Industry Leaders

Pierluigi Bruschetta

Pierluigi Bruschetta

New Jersey, NJ

Ron Kwok

Ron Kwok

San Francisco, CA

Haripriya Jain

Haripriya Jain

San Francisco, CA

Akira Robinson

Akira Robinson

Los Angeles, CA

Javier Picó

Javier Picó

Mexico City, Mexico

Boris Schlaak

Boris Schlaak

Berlin, Germany

Marco Pedrazzoli

Marco Pedrazzoli

Zug, Switzerland

Marina Ponomareva

Marina Ponomareva

Milan, Italy